These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 7540373)
1. Interaction of osteopontin with osteoclast integrins. Horton MA; Nesbit MA; Helfrich MH Ann N Y Acad Sci; 1995 Apr; 760():190-200. PubMed ID: 7540373 [TBL] [Abstract][Full Text] [Related]
2. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. Ross FP; Chappel J; Alvarez JI; Sander D; Butler WT; Farach-Carson MC; Mintz KA; Robey PG; Teitelbaum SL; Cheresh DA J Biol Chem; 1993 May; 268(13):9901-7. PubMed ID: 8486670 [TBL] [Abstract][Full Text] [Related]
3. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions. Shankar G; Gadek TR; Burdick DJ; Davison I; Mason WT; Horton MA Exp Cell Res; 1995 Aug; 219(2):364-71. PubMed ID: 7543851 [TBL] [Abstract][Full Text] [Related]
4. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Hruska KA; Rolnick F; Huskey M; Alvarez U; Cheresh D Ann N Y Acad Sci; 1995 Apr; 760():151-65. PubMed ID: 7540372 [No Abstract] [Full Text] [Related]
5. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin. Helfrich MH; Nesbitt SA; Dorey EL; Horton MA J Bone Miner Res; 1992 Mar; 7(3):335-43. PubMed ID: 1585836 [TBL] [Abstract][Full Text] [Related]
6. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. Duong LT; Rodan GA Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563 [TBL] [Abstract][Full Text] [Related]
8. Bone sialoprotein stimulates in vitro bone resorption. Raynal C; Delmas PD; Chenu C Endocrinology; 1996 Jun; 137(6):2347-54. PubMed ID: 8641185 [TBL] [Abstract][Full Text] [Related]
9. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. Miyauchi A; Alvarez J; Greenfield EM; Teti A; Grano M; Colucci S; Zambonin-Zallone A; Ross FP; Teitelbaum SL; Cheresh D J Biol Chem; 1991 Oct; 266(30):20369-74. PubMed ID: 1939092 [TBL] [Abstract][Full Text] [Related]
10. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Hruska KA; Rolnick F; Huskey M; Alvarez U; Cheresh D Endocrinology; 1995 Jul; 136(7):2984-92. PubMed ID: 7540546 [TBL] [Abstract][Full Text] [Related]
11. Binding of osteopontin to the osteoclast integrin alpha v beta 3. Miyauchi A; Alvarez J; Greenfield EM; Teti A; Grano M; Colucci S; Zambonin-Zallone A; Ross FP; Teitelbaum SL; Cheresh D Osteoporos Int; 1993; 3 Suppl 1():132-5. PubMed ID: 8461540 [TBL] [Abstract][Full Text] [Related]
12. Bone sialoprotein coated on glass and plastic surfaces is recognized by different beta 3 integrins. Flores ME; Heinegård D; Reinholt FP; Andersson G Exp Cell Res; 1996 Aug; 227(1):40-6. PubMed ID: 8806449 [TBL] [Abstract][Full Text] [Related]
13. Integrin function in osteoclasts. Rodan SB; Rodan GA J Endocrinol; 1997 Sep; 154 Suppl():S47-56. PubMed ID: 9379137 [TBL] [Abstract][Full Text] [Related]
14. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Flores ME; Norgård M; Heinegård D; Reinholt FP; Andersson G Exp Cell Res; 1992 Aug; 201(2):526-30. PubMed ID: 1639145 [TBL] [Abstract][Full Text] [Related]
15. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3. Hu DD; Hoyer JR; Smith JW J Biol Chem; 1995 Apr; 270(17):9917-25. PubMed ID: 7537271 [TBL] [Abstract][Full Text] [Related]
16. Osteopontin overview. Rodan GA Ann N Y Acad Sci; 1995 Apr; 760():1-5. PubMed ID: 7540370 [No Abstract] [Full Text] [Related]
17. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis. Dresner-Pollak R; Rosenblatt M J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325 [TBL] [Abstract][Full Text] [Related]
18. Integrins and signaling in osteoclast function. Duong LT; Lakkakorpi P; Nakamura I; Rodan GA Matrix Biol; 2000 May; 19(2):97-105. PubMed ID: 10842093 [TBL] [Abstract][Full Text] [Related]
19. Roles of osteopontin in bone remodeling. Heinegård D; Andersson G; Reinholt FP Ann N Y Acad Sci; 1995 Apr; 760():213-22. PubMed ID: 7540374 [No Abstract] [Full Text] [Related]
20. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]